Chemoprevention in ulcerative colitis: Narrowing the gap between clinical practice and research

被引:10
|
作者
Hawk, ET [1 ]
Viner, JL [1 ]
机构
[1] NCI, Gastrointestinal & Other Canc Res Grp, Div Canc Prevent, EPN, Bethesda, MD 20892 USA
关键词
D O I
10.7326/0003-4819-134-2-200101160-00017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
At present, it would be premature to offer ursodiol as a chemopreventive agent outside the context of a clinical trial. However, if the inverse association between ursodiol use and dysplasia prevalence described by Tung and colleagues in this issue is causal and true, it is a very exciting observation.
引用
收藏
页码:158 / 160
页数:3
相关论文
共 50 条